文献速递角膜与眼表疾病

2型糖尿病的眼表:病理生理及抗糖尿病药物的影响

The ocular surface in type 2 diabetes: pathophysiology and impact of anti-diabetic drugs.
PubMed 文献 · Prog Retin Eye Res · 2025-11-24

本文综述2型糖尿病患者眼表的结构、生化和神经病变改变,高血糖及代谢失衡导致泪膜不稳定、炎症、氧化应激和周围神经病变,参与干眼病、角膜愈合受损和角膜神经病变的发病。综述还评估二甲双胍、SGLT2抑制剂、GLP-1受体激动剂和胰岛素等抗糖尿病治疗对眼表的影响,近期研究提示这些药物联合血糖控制可能提供眼表保护益处。

要点

  • 高血糖及代谢失衡导致泪膜不稳定、炎症、氧化应激和周围神经病变,参与干眼病、角膜愈合受损和角膜神经病变的发病。
  • 血糖控制、炎症细胞因子和微血管损伤等全身因素直接影响眼表稳态。
  • 近期研究提示二甲双胍、SGLT2抑制剂、GLP-1受体激动剂和胰岛素联合血糖控制可能提供眼表保护益处。

核心结论

  • 全面理解这些因素可能有助于改善2型糖尿病眼表疾病的筛查、早期诊断和综合管理。

研究设计与样本

  • 本文为综述,回顾2型糖尿病患者眼表的结构、生化及神经病变改变,并评估抗糖尿病治疗对眼表的影响。

主要发现

  • 高血糖及相关代谢失衡导致泪膜不稳定、炎症、氧化应激和周围神经病变,参与干眼病、角膜愈合受损和角膜神经病变的发病。
  • 血糖控制、炎症细胞因子和微血管损伤等全身因素直接影响眼表稳态。
  • 近期研究提示二甲双胍、钠-葡萄糖共转运蛋白2(SGLT2)抑制剂、胰高血糖素样肽-1(GLP-1)受体激动剂和胰岛素联合血糖控制可能提供眼表保护益处。
  • 证据支持上述药物在减轻眼表炎症、促进角膜神经再生和改善泪膜稳态方面的作用。

临床怎么用

  • 全面理解这些因素可能有助于改善2型糖尿病眼表疾病的筛查、早期诊断和综合管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Type 2 diabetes is a chronic, systemic, metabolic disorder characterized by persistent hyperglycemia and associated with a broad spectrum of complications, including those affecting the ocular surface. This article reviews the structural, biochemical, and neuropathic changes observed in the ocular surface of patients with diabetes. Hyperglycemia and associated metabolic imbalances lead to tear film instability, inflammation, oxidative stress, and peripheral neuropathy, contributing to the pathogenesis of dry eye disease, impaired corneal wound healing and corneal neuropathy. In addition, systemic factors such as glycemic control, inflammatory cytokines, and microvascular impairment have direct impact on ocular surface homeostasis. This review also evaluates the effects of antidiabetic therapies on the ocular surface. Recent studies suggest that drugs such as metformin, sodium-glucose co-transporter 2 inhibitors, glucagon like peptide-1 receptor agonists, and insulin along with glucose control, may offer the ocular surface protective benefits. Evidence supports their roles in reducing ocular surface inflammation, promoting corneal nerve regeneration, and improving tear film homeostasis. A comprehensive understanding of these factors may facilitate improved screening, early diagnosis, and integrative management of ocular surface disorders in type 2 diabetes.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Singh I, Poynten AM, Krishnan AV, et al. The ocular surface in type 2 diabetes: pathophysiology and impact of anti-diabetic drugs. Prog Retin Eye Res. 2025. PMID: 41297876. doi:10.1016/j.preteyeres.2025.101417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。